A detailed history of Delta Financial Group, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Delta Financial Group, Inc. holds 6,740 shares of LLY stock, worth $6.16 Million. This represents 1.54% of its overall portfolio holdings.

Number of Shares
6,740
Previous 6,733 0.1%
Holding current value
$6.16 Million
Previous $3.93 Million 33.61%
% of portfolio
1.54%
Previous 1.23%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 30, 2024

BUY
$592.2 - $792.28 $4,145 - $5,545
7 Added 0.1%
6,740 $5.24 Million
Q4 2023

Jan 18, 2024

SELL
$525.19 - $619.13 $46,216 - $54,483
-88 Reduced 1.29%
6,733 $3.93 Million
Q3 2023

Oct 31, 2023

BUY
$434.7 - $599.3 $2.97 Million - $4.09 Million
6,821 New
6,821 $3.66 Million
Q1 2023

Apr 25, 2023

BUY
$310.63 - $364.82 $35,722 - $41,954
115 Added 8.37%
1,489 $512,000
Q4 2022

Feb 13, 2023

BUY
$321.55 - $374.67 $441,809 - $514,796
1,374 New
1,374 $501,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $869B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Delta Financial Group, Inc. Portfolio

Follow Delta Financial Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Delta Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Delta Financial Group, Inc. with notifications on news.